Assorted Gummies – 3000mg

Shroomies Microbites, Microdose with Shroomies’ delicious Microbites Assorted gummies. Its benefits can improve your emotional, psychological and spiritual well-being by lifting mood, giving a boost in clarity, and improving energy. The method of microdosing is often used to cope with anxiety, stress, and addiction.

Your well-being will be enhanced, while still being functional, with Shroomies’ Microbites.

Each tin contains 15 gummies, each at 200mg, totaling 3000mg per tin.

For microdosing: 1 gummy every 3 days in the morning

For pleasure: 3-5 gummies for beginners    OR    5-7 gummies for veterans

Ingredients: Sugar, Gelatin, Corn Syrup, Citric Acid, Natural & Artificial Flavours, Artificial Colour, Soy Lecithin | Active Ingredients: Psilocybin Mushroom via Lemon Tek Shroomies Microbites 3000mg Assorted Psilocybin provides favorable positive effects for most users. Taking one gummy every day helps you feel uplifted, increases your energy and focus, and improves your overall brain function. As a result, you’ll have an enhanced mood, and your performance will improve. All of the mentioned effects make Shroomies Psilocybin Microsites an option for treating fatigue, anxiety, and depression.Several studies claim that consuming small amounts of Psilocybin every day has better effects on the body in the long term than consuming a high dose once. Microdosing Psilocybin lets you enjoy its positive effects for a longer period.The practice of microdosing psychedelics involves ingesting sub-hallucinogenic amounts of a psychedelic substance (e.g. LSD, psilocybin) and has recently grown in popularity. The number of popular media accounts and book-length treatments of microdosing has been growing [1,2,3,4,5,6,7]. Online microdosing communities have grown to the tens of thousands with more than 40,000 users subscribing to the /r/microdosing subreddit (/r/microdosing subreddit, Reddit Inc, San Francisco, CA, USA). This public interest speaks to a social need for scientific studies to inform the public about the effects of microdosing. Initial scientific investigations of microdosing are just beginning [8,9,10,11] (Rosenbaum D, Weissman C, Hapke E, Hui K, Petranker R, Dinh-Williams L-A, et al.: Microdosing psychedelic substances: demographics, psychiatric comorbidities, and comorbid substance use, in preparation) and future directions remain unclear. While full-dose psychedelic research is growing in prominence and outcomes from full-dose studies can certainly inform microdosing studies, focusing solely on known full-dose outcomes could result in missing unanticipated benefits and challenges specific to microdosing. As such, beginning with an open, exploratory approach could result in a better understanding of the potential benefits and challenges specific to microdosing. The present study aims to provide a data-driven taxonomy describing the positive and negative experiences reported by microdosers from an open-ended analysis of microdosing-specific outcomes, summarizing high-potential avenues for focused experimental investigations.